P12.08 Targeting tumor-reduced drug accessibility to counteract organ-specific resistance to anti-CD22 immunotoxins

P12.08 Targeting tumor-reduced drug accessibility to counteract organ-specific resistance to anti-CD22 immunotoxins

Bibliographic Details
Main Authors:	F Muller, F Gsottberger, S Petkovic, L Nitschke, A Mackensen, K Wendland
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2024-03-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

Human CD22-Transgenic, Primary Murine Lymphoma Challenges Immunotherapies in Organ-Specific Tumor Microenvironments
by: Franziska Gsottberger, et al.
Published: (2021-09-01)

P12.08 THE ASSESSMENT OF ARTERY STIFFNESS IN YOUNG POPULATION WITH PRIMARY ARTERIAL HYPERTENSION
by: M. Walczak, et al.
Published: (2010-12-01)

12.08 SYSTOLIC HYPERTENSION MECHANISMS: EFFECT OF GLOBAL AND LOCAL PROXIMAL AORTA STIFFENING ON PULSE PRESSURE
by: P. Reymond, et al.
Published: (2011-11-01)

10.03 Long lasting alterations of the immunophenotype and cytokine signature of DLBCL survivors results in persisting immune dysfunction
by: F Muller, et al.
Published: (2024-03-01)

Cytotoxicity of the anti-CD22 immunotoxin HA22 (CAT-8015) against paediatric acute lymphoblastic leukaemia.
by: Mussai, F, et al.
Published: (2010)

Synthesis and crystal structure of Nd1.57Ce2.56Sr3.87CuO12.08
by: Miyazaki, Y, et al.
Published: (1999)

P1314: PURIFICATION AND FUNCTIONAL CHARACTERIZATION OF CD34+ CELLS FROM CRYOPRESERVED APHERESIS PRODUCTS OF PATIENTS WITH BONE MARROW INFILTRATING MALIGNANCIES
by: F. Muller, et al.
Published: (2022-06-01)

Two Saporin-Containing Immunotoxins Specific for CD20 and CD22 Show Different Behavior in Killing Lymphoma Cells
by: Letizia Polito, et al.
Published: (2017-05-01)

Frederick II of Hohenstaufen (1208–1250)
by: Mirko Vagnoni
Published: (2021-08-01)

Standardization of the Pharmaceutical Substance of the Drug LCS-1208
by: E. V. Ignateva, et al.
Published: (2021-08-01)

الفســاد الإداري في المملكة الحيثية (1650- 1208 ق.م) "Administrative Corruption in the Hittite Kingdom (1650- 1208 B.C)"
by: Emad Abdel Azeem Ashour
Published: (2024-01-01)

Immunotoxins: The Role of the Toxin
by: David FitzGerald, et al.
Published: (2013-08-01)

Interactions Between Pseudomonas Immunotoxins and the Plasma Membrane: Implications for CAT-8015 Immunotoxin Therapy
by: Monika Bokori-Brown, et al.
Published: (2018-11-01)

CD3-immunotoxin mediated depletion of T cells in lymphoid tissues of rhesus macaques
by: Lan Wang, et al.
Published: (2023-09-01)

Improving the cytotoxicity of immunotoxins by reducing the affinity of the antibody in acidic pH
by: Xiaoyu Liu, et al.
Published: (2023-08-01)

Bouganin, an Attractive Weapon for Immunotoxins
by: Massimo Bortolotti, et al.
Published: (2018-08-01)

Immunotoxin Therapy for Lung Cancer
by: Li-Yi Xie, et al.
Published: (2017-01-01)

VALIDATION OF METHODS OF QUANTITATIVE DETERMINATION LHS-1208 IN THE LYOPHILIZED DOSAGE FORM
by: I. D. Gulyakin, et al.
Published: (2019-01-01)

Macrophage-Targeted Therapy: CD64-Based Immunotoxins for Treatment of Chronic Inflammatory Diseases
by: Theo Thepen, et al.
Published: (2012-09-01)

A novel immunotoxin reveals a new role for CD321 in endothelial cells.
by: Takeshi Fukuhara, et al.
Published: (2017-01-01)

Genetic polymorphisms in MIR1208 and MIR5708 are associated with susceptibility to COPD in the Chinese population
by: Y. Zhou, et al.
Published: (2023-01-01)

Immunotoxins: From Design to Clinical Application
by: Robert J. Kreitman, et al.
Published: (2021-11-01)

Toxin and Immunotoxin Based Therapeutic Approaches
by: Massimo Bortolotti, et al.
Published: (2022-01-01)

Antibody-Based Immunotoxins for the Treatment of Cancer
by: Nurit Becker, et al.
Published: (2012-05-01)

“Convective Hot Tower” Signatures and Rapid Intensification of Severe Typhoon Vicente (1208)
by: H.Y. Yeung
Published: (2013-05-01)

Humanized CD7 nanobody-based immunotoxins exhibit promising anti-T-cell acute lymphoblastic leukemia potential
by: Yu Y, et al.
Published: (2017-03-01)

Development of Recombinant Immunotoxins for Hairy Cell Leukemia
by: Robert J. Kreitman, et al.
Published: (2020-08-01)

Mesothelin-Targeted Recombinant Immunotoxins for Solid Tumors
by: Brendan L. Hagerty, et al.
Published: (2020-06-01)

Antibody-Based Immunotoxins for Colorectal Cancer Therapy
by: Laura Sanz, et al.
Published: (2021-11-01)

Immunotoxins: Targeted Toxin Delivery for Cancer Therapy
by: Xin Mei, et al.
Published: (2019-08-01)

Immunotoxin: A new tool for cancer therapy
by: Hossein Allahyari, et al.
Published: (2017-02-01)

Review of the official opponent on PhD (Law) thesis by S. A. Buchakov “Illegal external migration in Russia: criminological situation and counteraction policy”, major code 12.00.08
by: S. F. Milyukov
Published: (2020-06-01)

Molecular Mechanisms of Anticancer Activity of N-Glycosides of Indolocarbazoles LCS-1208 and LCS-1269
by: Roman G. Zenkov, et al.
Published: (2021-12-01)

MiR-1208 Increases the Sensitivity to Cisplatin by Targeting TBCK in Renal Cancer Cells
by: Eun-Ae Kim, et al.
Published: (2019-07-01)

PREPARATION AND ANALYSIS OF LYOPHILIZED DOSAGE FORM LHS-1208 BY THIN CHROMATOGRAPHY AND A SPECTROPHOTOMETERY
by: I. D. Gulyakin, et al.
Published: (2019-01-01)

First-in-human phase 1 study of IT1208, a defucosylated humanized anti-CD4 depleting antibody, in patients with advanced solid tumors
by: Kohei Shitara, et al.
Published: (2019-07-01)

Anti-Human Endoglin (hCD105) Immunotoxin—Containing Recombinant Single Chain Ribosome-Inactivating Protein Musarmin 1
by: Begoña Barriuso, et al.
Published: (2016-06-01)

Targeted inhibition of protein synthesis renders cancer cells vulnerable to apoptosis by unfolded protein response
by: Franziska Gsottberger, et al.
Published: (2023-08-01)

Interleukin-8-251 A/T and CXCR2 +1208 C/T Genes Polymorphisms in Chronic Rhinosinusitis
by: Bijan Khademi, et al.
Published: (2011-01-01)

Interleukin-8-251 A/T and CXCR2 +1208 C/T Genes Polymorphisms in Chronic Rhinosinusitis
by: Bijan Khademi, et al.
Published: (2011-01-01)